Diabetic retinopathy: An update on treatment

American Journal of Medicine

Volumn 123, Issue 3, 2010, Pages 213-216

  Fante, Ryan J ^a   Durairaj, Vikram D ^a   Oliver, Scott C N ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Antiangiogenic therapy; Diabetic retinopathy; Intravitreal injection; Laser photocoagulation; Macular edema; Neovascularization; Retina; Vascular endothelial growth factor; Vitrectomy

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VEGF TRAP EYE; ANGIOGENESIS INHIBITOR;

ARTICLE; BLINDNESS; BLOOD VESSEL INJURY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; HYPERGLYCEMIA; LASER COAGULATION; PRIORITY JOURNAL; ADULT; CASE REPORT; HUMAN; INJECTION; METHODOLOGY; VITRECTOMY; VITREOUS BODY;

ADULT; ANGIOGENESIS INHIBITORS; DIABETIC RETINOPATHY; HUMANS; INJECTIONS; LASER COAGULATION; VITRECTOMY; VITREOUS BODY;

EID: 77950469687     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.09.020     Document Type: Article

References (20)

1. Centers for Disease Control. National Diabetes Fact Sheet: 2007. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control; 2008.
2. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008; 115:1859-1868.
3. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141:446-455.
4. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-916. (Pubitemid 47311296)
5. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58. (Pubitemid 38032183)
6. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. Available at: http://one.aao.org/CE/ PracticeGuidelines/PPP.aspx. Accessed August 27, 2009.
7. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98:766-785.
8. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology. 1995;102: 647-661.
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352(9131):837-853.
10. Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004;122: 1631-1640. (Pubitemid 39473407)
11. Estacio RO, Jeffers BW, Gifford N, et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23(Suppl 2):B54-B64. (Pubitemid 30185779)
12. Indications for photocoagulation treatment of diabetic retinopathy. The Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin. 1987;27:239-253.
13. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial. Arch Ophthalmol. 1990;108:958-964.
14. Tolentino MJ, McLeod DS, Taomoto M, et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol. 2002;133:373-385. (Pubitemid 34171588)
15. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487. (Pubitemid 24356306)
16. Adamis AP, Altaweel M, Bressler NM, et al. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology. 2006;113:23-28. (Pubitemid 43021723)
17. Arevalo JF, Sanchez JG, Fromow-Guerra J. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the PACORES at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol. 2009;247:735-743.
18. Diabetic Retinopathy Clinical Research Network. DRCR Studies. Available at: http://public.drcr.net/. Accessed July 2009.
19. Yilmaz T, Weaver CD, Gallagher MJ, et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology. 2009;116:902-911.
20. Beck RW, Edwards AR, Aiello LP, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009;127:245-251.